[1] |
DA FONSECA B M, MORENO I E, BARROSO M, et al. Determination of seven selected antipsychotic drugs in human plasma using microextraction in packed sorbent and gas chromatography-tandem mass spectrometry[J]. Anal Bioanal Chem, 2013, 405(12):3953-3963.
DOI
URL
|
[2] |
SERRI O, CHIK C L, UR E, et al. Diagnosis and management of hyperprolactinemia[J]. CMAJ, 2003, 169(6):575-581.
|
[3] |
中华医学会精神医学分会精神分裂症协作组. 精神分裂症患者代谢综合征管理的中国专家共识[J]. 中华精神科杂志, 2020, 53(1):3-10.
|
[4] |
ALOSAIMI F D, FALLATA E O, ABALHASSAN M, et al. Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications[J]. Int J Psychiatry Clin Pract, 2018, 22(4):274-281.
DOI
URL
|
[5] |
AURIEMMA R S, DE ALCUBIERRE D, PIRCHIO R, et al. Glucose abnormalities associated to prolactin secreting pituitary adenomas[J]. Front Endocrinol(Lausanne), 2019, 10:327.
|
[6] |
RAMPINO A, MARAKHOVSKAIA A, SOARES-SILVA T, et al. Antipsychotic drug responsiveness and dopamine receptor signaling;old players and new prospects[J]. Front Psychiatry, 2019, 9:702.
|
[7] |
ANDERSEN M, GLINTBORG D. Metabolic syndrome in hyperprolactinemia[J]. Front Horm Res, 2018, 49:29-47.
|
[8] |
ZHANG C, MAO Y, SONG L. Precise treatments for schizophrenia:where is the way forward?[J]. Gen Psychiatr, 2018, 31(1):e000002.
|
[9] |
JING Y, WANG X, YU J, et al. Associations of serum sex hormone binding globulin with bone mineral densities and higher 10-year probability of fractures in postmenopausal women with type 2 diabetes mellitus[J]. Ann Transl Med, 2019, 7(18):457.
DOI
URL
|
[10] |
HE S, YU W J, WANG X, et al. Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids[J]. Gen Psychiatr, 2020, 33(4):e100206.
|
[11] |
DUMONTAUD M, KORCHIA T, KHOUANI J, et al. Sexual dysfunctions in schizophrenia:Beyond antipsychotics. A systematic review[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2020, 98:109804.
DOI
URL
|
[12] |
陈周文, 张四美, 万凤. 利培酮对首发精神分裂症患者泌乳素的影响及相关影响因素分析[J]. 临床心身疾病杂志, 2017, 23(4):25-27.
|
[13] |
LIANG Y, HUANG J, TIAN J B, et al. Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia[J]. Clin Interv Aging, 2016, 11:153-157.
|
[14] |
LI J, RICE M S, HUANG T, et al. Circulating prolactin concentrations and risk of type 2 diabetes in US women[J]. Diabetologia, 2018, 61(12):2549-2560.
DOI
URL
|
[15] |
ZHANG Y, WANG Q, REYNOLDS G P, et al. Metabolic effects of 7 antipsychotics on patients with schizophrenia:a short-term,randomized,open-label,multicenter,pharmacologic trial[J]. J Clin Psychiatry, 2020, 81(3):19m12785.
|